Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In Czech Republic
This study has finished and is no longer accepting participants.
In AustraliaA 4-week, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers
This study has finished and is no longer accepting participants.
In MumbaiThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In HungaryStudy of Evaluating Quetiapine in Improving Sleep Quality of Schizophrenia
This study has finished and is no longer accepting participants.
In GuangzhouThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In ItalyA 40-week Open-Label Extension Study to Evaluate TNX-102 SL 5.6 mg Taken Daily at Bedtime in Patients With PTSD
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockThis study has finished and is no longer accepting participants.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In BelgiumA Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study With an Open-Label Extension Evaluating Extended Release OROS® Paliperidone in the Prevention of Recurrence in Subjects With Schizophrenia - Open Label Phase
This study has finished and is no longer accepting participants.
Location not clearly listedA 52 week open-label extension study to evaluate the safety and tolerability of licarbazepine 750-2500 mg/d in the treatment of manic episodes of bipolar I disorder
Original registry wording; source language not specified.
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In AustriaThis study evaluated the safety of Paliperidone for people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedA 52-week open-label extension study to evaluate the safety and tolerability of licarbazepine 750-2000 mg/d in the treatment of manic episodes of bipolar I disorder
Original registry wording; source language not specified.
This study ended early.
Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.
In FinlandWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.